10-60070942-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020987.5(ANK3):c.9939C>A(p.Asp3313Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,788 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D3313V) has been classified as Uncertain significance.
Frequency
Consequence
NM_020987.5 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual disability-hypotonia-spasticity-sleep disorder syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- intellectual disabilityInheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
- Tourette syndromeInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020987.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ANK3 | NM_020987.5 | MANE Select | c.9939C>A | p.Asp3313Glu | missense | Exon 37 of 44 | NP_066267.2 | ||
| ANK3 | NM_001204404.2 | c.4409-2933C>A | intron | N/A | NP_001191333.1 | ||||
| ANK3 | NM_001320874.2 | c.4406-2933C>A | intron | N/A | NP_001307803.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ANK3 | ENST00000280772.7 | TSL:1 MANE Select | c.9939C>A | p.Asp3313Glu | missense | Exon 37 of 44 | ENSP00000280772.1 | ||
| ANK3 | ENST00000373827.6 | TSL:1 | c.4388-2933C>A | intron | N/A | ENSP00000362933.2 | |||
| ANK3 | ENST00000355288.6 | TSL:1 | c.1808-2933C>A | intron | N/A | ENSP00000347436.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461788Hom.: 0 Cov.: 34 AF XY: 0.00000275 AC XY: 2AN XY: 727196 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Inborn genetic diseases Uncertain:1
The c.9939C>A (p.D3313E) alteration is located in exon 37 (coding exon 37) of the ANK3 gene. This alteration results from a C to A substitution at nucleotide position 9939, causing the aspartic acid (D) at amino acid position 3313 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at